Alicia Casey

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

Medicine, Pediatrics, Pharmacotherapy +12

Genotype–Phenotype Correlations for Infants and Children with ABCA3 Deficiency

Jennifer Wambach, Alicia Casey, Martha P. Fishman et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 218 citations

Life Sciences, Genetics, Pediatrics +17

Emergent high fatality lung disease in systemic juvenile arthritis

Vivian E Saper, Guangbo Chen, Gail Deutsch et al. · Annals of the Rheumatic Diseases · 2019 · 216 citations · Full text

Medicine, Pathology, Hypersensitivity +10

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 126 citations · Full text

Pharmacy, Pharmacotherapy, Good Clinical Practice +8

Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity

Alexander R. Opotowsky, Michael J. Landzberg, Michael G. Earing et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2014 · 82 citations · Full text

Medicine, Cardiology, Physiology +17